Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393001 · ClinicalTrials.gov registry record
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 50
- Enrollment target
NCT02393001: Completed study, sponsored by University of Florida.
NCT02393001 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02393001 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if a very sensitive chemistry lab analyzer can be used to smell a skin cancer (like melanoma) similar to some dogs.
Primary Outcome
Determine if the melanomas have unique identifying spectra that might be applied to noninvasive melanoma skin cancer screening in lieu of taking a biopsy
Interventions
- OTHER Dermatology patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-10-03 |
What the finished NCT02393001 record still lists
NCT02393001 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dermatology patients is the first listed.
NCT02393001 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02393001 about?
NCT02393001 is a clinical study titled "Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques". The purpose of this research study is to determine if a very sensitive chemistry lab analyzer can be used to smell a skin cancer (like melanoma) similar to some dogs.
What is the current status of trial NCT02393001?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2015-05. Estimated completion is 2017-10-03.
What interventions are being tested in trial NCT02393001?
The interventions under investigation include: Dermatology patients (OTHER).
Who is sponsoring clinical trial NCT02393001?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia